Vaccination with the E7 peptide-loaded MSR vaccine resulted in strong infiltration of antigen-specific CD8+ T cells, tumour growth inhibition, and the moderately prolonged survival in HPV+ oral tumour mice [586]. Here, CD8A is linked to neoplasm.